Turning complex molecular data into clinical advantage
As infectious disease programs face increasing pressure to generate high-quality data faster, integrated molecular approaches are becoming essential to early-phase success. This webinar explores how combining next-generation sequencing (NGS), droplet digital PCR (ddPCR), and 3' RNA-seq (QuantSeq) can support more precise pathogen detection, resistance monitoring, and host-response biomarker discovery.
Through real-world workflows, viewers will gain practical insight into ddPCR-based pathogen identification, influenza whole-genome sequencing for variant and resistance tracking, and high-throughput transcriptomic profiling to characterize host response. The session demonstrates how these complementary platforms work together within hVIVO’s clinical and laboratory ecosystem to accelerate infectious disease research and antiviral development.
Key Takeaways Include:
- How integrated ddPCR and NGS workflows enhance data quality in infectious disease studies
- Practical applications for pathogen quantification, resistance surveillance, and host-response biomarker discovery
- Operational considerations for implementing advanced molecular strategies in early-phase clinical programs
- Where these technologies can most effectively support challenge studies and antiviral development timelines
Speaker Details
Chris Forsdyke
Head Laboratory Services, hVIVO
Martin Larke
Principal NGS Biostatistician, hVIVO
Chelsea Pratt
Biopharma Segment Marketing Manager, Bio-Rad Laboratories
Francesca Manni
Territory Account Manager, Illumina
Inspire. Connect. Innovate.
